Cancer recurrence: An important but missing variable in national cancer registries

Annals of Surgical Oncology

Volumn 21, Issue 5, 2014, Pages 1520-1529

  In, Haejin ^a,b   Bilimoria, Karl Y ^a,c   Stewart, Andrew K ^a   Wroblewski, Kristen E ^b   Posner, Mitchell C ^b   Talamonti, Mark S ^d   Winchester, David P ^a,d  

^a American College of Surgns   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; COLON CANCER; COMORBIDITY; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PANCREAS CANCER; TERTIARY CARE CENTER; THYROID CANCER; ADOLESCENT; COMPLICATION; EPIDEMIOLOGY; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PATHOLOGY; PROGNOSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS; POPULATION SURVEILLANCE; PROGNOSIS; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 84898836611     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3516-x     Document Type: Article

References (18)

1. National Cancer Data Base (NCDB). Available at: http://www.facs.org/ cancer/ncdb/. Accessed 8 July 2013.
2. Surveillance Epidemiology and End Results (SEER). Available at: http://seer.cancer.gov/. Accessed July 8, 2013.
3. National Program of Cancer Registries (NPCR). Available at: http://www.cdc.gov/cancer/npcr/. Accessed 8 July 2013.
4. North American Association of Central Cancer Registries (NAACCR). Available at: http://www.naaccr.org/StandardsandRegistryOperations/VolumeII. aspx. Accessed 8 July 2013.
5. Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: A clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85:1-3. (Pubitemid 38036733)
6. Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: A powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683-90.
7. Williams RT, Stewart AK, Winchester DP. (2012) Monitoring the delivery of cancer care: Commission on Cancer and National Cancer Data Base. Surg Oncol Clin N Am. 21:377-88.
8. Facility Oncology Registry Data Standards (FORDS). Revised for 2013: Commission on Cancer. Available at: http://www.facs.org/cancer/coc/fordsmanual. html.
9. Wolfinger R, O'Connell M. Generalized linear mixed models a pseudo-likelihood approach. J Stat Comput Simul. 1993;48:233-43.
10. Liao JG, Lipsitz SR. A type of restricted maximum likelihood estimator of variance components in generalized linear mixed models. Biometrika., 2002;89:401-9. (Pubitemid 41311989)
11. Cancer Program and Data Standards. Available at: http://www.facs.org/ cancer/coc/standards.html. Accessed 8 July 2013.
12. Shi Q, You YN, Nelson H, Allen MS, Winchester D, Stewart A, et al. Cancer registries: A novel alternative to long-term clinical trial follow-up based on results of a comparative study. Clinical Trials. 2010;7:686-95.
13. Earle CC, Nattinger AB, Potosky AL, Lang K, Mallick R, Berger M, et al. Identifying cancer relapse using SEER-Medicare data. Med Care. 2002;40(IV):75-81.
14. Lamont EB, Herndon JE, 2nd, Weeks JC, Weeks JC, Henderson IC, Earle CC, et al. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst. 2006;98:1335-8. (Pubitemid 44530729)
15. Yang Y, Mauldin PD, Ebeling M, Hulsey TC, Liu B, Thomas MB, et al. Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer. 2013;119:1512-20.
16. Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value Health. 2008;11:213-20. (Pubitemid 351473603)
17. Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, et al. Hazard of recurrence among women after primary breast cancer treatment - a 10-year follow-up using data from SEER-Medicare. Cancer Epidemiol Biomarkers Prev. 2012;21:800-9.
18. Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, et al. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2012. doi: 10.1097/MLR.0b013e318277eb6f.